Replies to post #213 on Vanda Pharmaceuticals, Inc. (VNDA)

[surf1944]

7:07AM Vanda Pharma enters into an exclusive license agreement with Biotoscana Farma S.A. for Commercialization of Fanapt in Argentina (VNDA) 7.18 : Under the terms of the agreement, Biotoscana will seek regulatory approval for Fanapt in Argentina. Vanda will supply Biotoscana with Fanapt drug product for packaging and sale and Biotoscana's CNS specialty sales force will promote Fanapt to psychiatrists in Argentina.